Human amniotic mesenchymal stromal cell-derived exosomes promote neuronal function by inhibiting excessive apoptosis in a hypoxia/ischemia-induced cerebral palsy model: A preclinical study - 22/03/24
, Jing Gao a, b, ⁎ Abstract |
Background |
Cerebral palsy (CP) is a condition resulting from perinatal brain injury and can lead to physical disabilities. Exosomes derived from human amniotic mesenchymal stromal cells (hAMSC-Exos) hold promise as potential therapeutic options.
Objective |
This study aimed to investigate the impact of hAMSC-Exos on neuronal cells and their role in regulating apoptosis both in vitro and in vivo.
Methods |
hAMSC-Exos were isolated via ultracentrifugation and characterized via transmission electron microscopy, particle size analysis, and flow cytometry. In vitro, neuronal damage was induced by lipopolysaccharide (LPS). CP rat models were established via left common carotid artery ligation. Apoptosis levels in cells and CP rats were assessed using flow cytometry, quantitative reverse transcription polymerase chain reaction (RT–qPCR), Western blotting, and TUNEL analysis.
Results |
The results demonstrated successful isolation of hAMSC-Exos via ultracentrifugation, as the isolated cells were positive for CD9 (79.7%) and CD63 (80.2%). Treatment with hAMSC-Exos significantly mitigated the reduction in cell viability induced by LPS. Flow cytometry revealed that LPS-induced damage promoted apoptosis, but this effect was attenuated by treatment with hAMSC-Exos. Additionally, the expression of caspase-3 and caspase-9 and the Bcl-2/Bax ratio indicated that excessive apoptosis could be attenuated by treatment with hAMSC-Exos. Furthermore, tail vein injection of hAMSC-Exos improved the neurobehavioral function of CP rats. Histological analysis via HE and TUNEL staining showed that apoptosis-related damage was attenuated following hAMSC-Exo treatment.
Conclusions |
In conclusion, hAMSC-Exos effectively promote neuronal cell survival by regulating apoptosis, indicating their potential as a promising therapeutic option for CP that merits further investigation.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | hAMSC-Exos enhance neurobehavioral outcomes in cerebral palsy model rats. |
• | hAMSC-Exos counteract LPS-induced damage, preserving neuronal viability in vitro. |
• | Caspase-3 expression, Caspase-9 expression, the Bcl-2/Bax ratio suggest that hAMSC-Exos suppress apoptosis. |
• | hAMSC-Exos have potential clinical value in cerebral palsy treatment. |
Key words : Human amniotic mesenchymal stromal cells, Exosomes, Cerebral palsy, Apoptosis, Stem cells
Plan
Vol 173
Article 116321- avril 2024 Retour au numéro
Article précédent
- Ethanol binge drinking exposure during adolescence displays long-lasting motor dysfunction related to cerebellar neurostructural damage even after long-term withdrawal in female Wistar rats
- Igor Gonçalves de Oliveira, Letícia Yoshitome Queiroz, Carla Cristiane Soares da Silva, Sabrina Carvalho Cartágenes, Luanna Melo Pereira Fernandes, Fábio José Coelho de Souza-Junior, Leonardo Oliveira Bittencourt, Rafael Rodrigues Lima, Manoela Domingues Martins, Tuany Rafaeli Schmidt, Enéas Andrade Fontes-Junior, Cristiane do Socorro Ferraz Maia
- Autophagy regulation and redox perturbation by transcrocetin suppress the growth of endometriosis
- Jiyeon Ham, Jisoo Song, Gwonhwa Song, Whasun Lim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?